GGrantIndex
Sort

24,576 grants matching microbiome

Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model

$779,786
Gadi Wollstein · New York University School Of Medicine · R01 · FY2023 · EY

Role of Gut Microbial Dysbiosis and Aging on HIV-associated neurocognitive and brain dysfunction

$779,748
Shirish S Barve · University Of Louisville · R01 · FY2018 · AG

Clinical Risk Factors for Primary Graft Dysfunction

$779,646
Jason D Christie · University Of Pennsylvania · R01 · FY2016 · HL

Lung Microbiome and Pulmonary Inflammation/Immunity in HIV Infection

$779,491
Homer L Twigg · Indiana University Indianapolis · U01 · FY2009 · HL

NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUT

$779,329
Hyon K Choi · Massachusetts General Hospital · R01 · FY2022 · AR

Managing Atherosclerosis by Modulating HDL Function

$779,185
M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2022 · HL

Social Isolation and Discrimination as Stressors Influencing Brain-Gut Microbiome Alterations among Filipino and Mexican American

$779,086
Arpana Church · University Of California Los Angeles · R01 · FY2021 · MD

Impact of the Intestinal Microbiome on HIV/SIV Vaccines

$778,914
Megan T Baldridge · Washington University · R01 · FY2019 · OD

Early Life B-cell and plasma cell development in the human Spleen: a new paradigm for lifelong immunity

$778,829
Eliver Ghosn · Emory University · R01 · FY2025 · AI

Microbiome Plasticity and Pathogenicity in Older Adults: Baselines and Transitions from Skilled Nursing Care

$778,801
Julia Oh · Jackson Laboratory · R56 · FY2019 · AG

Genomics of bacterial pathogens: host response, persistence and transmission

$778,440
Ashlee Miriam Earl · Broad Institute, Inc. · U19 · FY2014 · AI

Data Management Analysis and Resources Dissemination Core

$778,169
William James Salerno · Baylor College Of Medicine · U19 · FY2021 · AI

Development of Engineered Native Bacteria as a Tool for Functional Manipulation of the Gut Microbiome

$778,137
Amir Zarrinpar · University Of California, San Diego · R01 · FY2024 · AI

A Longitudinal Study of Periodontal Infections and Alzheimer's Disease: The WHICAP Ancillary Study of Oral Health

$778,128
James McCallum Noble · Columbia University Health Sciences · R01 · FY2024 · AG

Modulation of lung immunity by epithelial cells from older individuals

$778,032
Anna Karolina Palucka · Jackson Laboratory · U19 · FY2025 · AI

Genomics of Inflammatory Bowel Disease

$777,981
Leah Claire Kottyan · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · AI

Preventing GVHD by inhibition of alloantigen presentation in the gut

$777,776
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2022 · HL

Translational Training Program in Pulmonary Biology and Medicine

$777,723
Melanie Koenigshoff · University Of Pittsburgh At Pittsburgh · T32 · FY2025 · HL

Is Obesity an Infectious Disease?: Gut bacterial and fungal translocation as an underappreciated driver of visceral adipose expansion.

$777,691
Suzanne Devkota · Cedars-Sinai Medical Center · DP1 · FY2025 · DK

Genetic Control of Addiction by Host and Microbiome

$777,588
George M Weinstock · Jackson Laboratory · U01 · FY2021 · DA

Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis

$777,500
V Michael Holers · University Of Colorado Denver · P30 · FY2021 · AR

Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi

$777,498
David R Andes · University Of Wisconsin-Madison · R01 · FY2022 · AI

Natural History of Chlamydia trachomatis genital tract infection in women

$777,437
Catherine M O'Connell · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI

Commensal microbiome impact on CD4 T cell lymphopenia in HIV-1 infection

$777,412
Souheil Antoine Younes · Emory University · R01 · FY2022 · AG

Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selection

$777,408
Kieran O'Brien · University Of California, San Francisco · R01 · FY2025 · AI